Clinicians in 25 countries prefer to use lower levels of oxygen to resuscitate preterm infants at birth

Abstract

Clinicians currently favour lower SpO2 targets for preterm resuscitation, despite acknowledging the lack of evidence for benefit or harm, and 65% would join a clinical trial.